Copyright
©The Author(s) 2024.
World J Stem Cells. May 26, 2024; 16(5): 591-603
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.591
Published online May 26, 2024. doi: 10.4252/wjsc.v16.i5.591
Figure 1 Ginsenoside Rg1 prevents myelosuppression.
A: Chemical structure of ginsenoside Rg1; B: Flowchart of experiments; C: Body weight plot of mice; D: Hematoxylin-eosin (HE) staining of marrow sample; E: HE staining of thymus; F: HE staining of spleen; G: Rg1 increased cell numbers in the peripheral blood of mice with myelosuppression. For all the statistical graphs: n = 5 mice per group. aP < 0.05, bP < 0.01, compared to the control group; cP < 0.05, dP < 0.01, compared to the cyclophosphamide (CTX) group. HGB: Hemoglobin; PLT: Platelets; RBC: Red blood cells; WBC: White blood cells.
- Citation: Wang JB, Du MW, Zheng Y. Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway. World J Stem Cells 2024; 16(5): 591-603
- URL: https://www.wjgnet.com/1948-0210/full/v16/i5/591.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i5.591